Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Gross Margin (2018 - 2025)

AVITA Medical (RCEL) has disclosed Gross Margin for 7 consecutive years, with 15.56% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 7380.0% year-over-year to 15.56%, compared with a TTM value of 27.65% through Dec 2025, down 5890.0%, and an annual FY2025 reading of 82.98%, down 335.0% over the prior year.
  • Gross Margin was 15.56% for Q4 2025 at AVITA Medical, down from 16.52% in the prior quarter.
  • Across five years, Gross Margin topped out at 89.35% in Q4 2024 and bottomed at 15.56% in Q4 2025.
  • Average Gross Margin over 4 years is 73.02%, with a median of 84.27% recorded in 2023.
  • The sharpest move saw Gross Margin surged 4403bps in 2023, then tumbled -7380bps in 2025.
  • Year by year, Gross Margin stood at 85.75% in 2022, then grew by 2bps to 87.35% in 2023, then grew by 2bps to 89.35% in 2024, then crashed by -83bps to 15.56% in 2025.
  • Business Quant data shows Gross Margin for RCEL at 15.56% in Q4 2025, 16.52% in Q3 2025, and 82.02% in Q2 2025.